OneArm2stage (Q86702): Difference between revisions
From MaRDI portal
Swh import (talk | contribs) SWHID from Software Heritage |
Added link to MaRDI item. |
||||||||||||||
(17 intermediate revisions by 3 users not shown) | |||||||||||||||
description / en | description / en | ||||||||||||||
Phase II Single-Arm Two-Stage Designs with Time-to-Event Outcomes | |||||||||||||||
Property / programmed in | |||||||||||||||
Property / programmed in: R / rank | |||||||||||||||
Property / last update | |||||||||||||||
| |||||||||||||||
Property / last update: 1 December 2022 / rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Xiaomeng Yuan / rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Haitao Pan / rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Jianrong Wu / rank | |||||||||||||||
Property / copyright license | |||||||||||||||
Property / copyright license: GNU General Public License / rank | |||||||||||||||
Property / copyright license: GNU General Public License / qualifier | |||||||||||||||
Property / depends on software | |||||||||||||||
Property / depends on software: R / rank | |||||||||||||||
Property / depends on software: R / qualifier | |||||||||||||||
Property / imports | |||||||||||||||
Property / imports: survival / rank | |||||||||||||||
Property / imports | |||||||||||||||
Property / imports: utils / rank | |||||||||||||||
Property / imports | |||||||||||||||
Property / imports: flexsurv / rank | |||||||||||||||
Property / imports | |||||||||||||||
Property / imports: IPDfromKM / rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Two‐stage phase II survival trial design / rank | |||||||||||||||
Property / Software Heritage ID | |||||||||||||||
Property / Software Heritage ID: swh:1:snp:8c5c3b90acb6d62caa57048feec1766320a1ef69 / rank | |||||||||||||||
Property / Software Heritage ID: swh:1:snp:8c5c3b90acb6d62caa57048feec1766320a1ef69 / qualifier | |||||||||||||||
Property / Software Heritage ID: swh:1:snp:8c5c3b90acb6d62caa57048feec1766320a1ef69 / qualifier | |||||||||||||||
| |||||||||||||||
Property / software version identifier | |||||||||||||||
1.1.4 | |||||||||||||||
Property / software version identifier: 1.1.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / software version identifier: 1.1.4 / qualifier | |||||||||||||||
publication date: 7 September 2022
| |||||||||||||||
Property / software version identifier | |||||||||||||||
1.2.1 | |||||||||||||||
Property / software version identifier: 1.2.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / software version identifier: 1.2.1 / qualifier | |||||||||||||||
publication date: 9 October 2023
| |||||||||||||||
Property / programmed in | |||||||||||||||
Property / programmed in: R / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / last update | |||||||||||||||
9 October 2023
| |||||||||||||||
Property / last update: 9 October 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / description | |||||||||||||||
Two-stage design for single-arm phase II trials with time-to-event endpoints (e.g., clinical trials on immunotherapies among cancer patients) can be calculated using this package. Two notable advantages of the package: 1) It provides flexible choices from three design methods (optimal, minmax, and admissible), and 2) the power ofthe design is more accurately calculated using the exact variance in theone-sample log-rank test. The package can be used for 1) planning the samplesizes and other design parameters, and 2) conducting the interim and finalanalyses for the Go/No-go decisions. More details about the design methodcan be found in: Wu, J, Chen L, Wei J, Weiss H, Chauhan A. (2020).<doi:10.1002/pst.1983>. | |||||||||||||||
Property / description: Two-stage design for single-arm phase II trials with time-to-event endpoints (e.g., clinical trials on immunotherapies among cancer patients) can be calculated using this package. Two notable advantages of the package: 1) It provides flexible choices from three design methods (optimal, minmax, and admissible), and 2) the power ofthe design is more accurately calculated using the exact variance in theone-sample log-rank test. The package can be used for 1) planning the samplesizes and other design parameters, and 2) conducting the interim and finalanalyses for the Go/No-go decisions. More details about the design methodcan be found in: Wu, J, Chen L, Wei J, Weiss H, Chauhan A. (2020).<doi:10.1002/pst.1983>. / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Xiaomeng Yuan / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Haitao Pan / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / author | |||||||||||||||
Property / author: Jianrong Wu / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / copyright license | |||||||||||||||
Property / copyright license: GNU General Public License / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / copyright license: GNU General Public License / qualifier | |||||||||||||||
edition/version: ≥ 3 (English) | |||||||||||||||
Property / imports | |||||||||||||||
Property / imports: survival / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / imports | |||||||||||||||
Property / imports: utils / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / imports | |||||||||||||||
Property / imports: flexsurv / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / imports | |||||||||||||||
Property / imports: IPDfromKM / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / cites work | |||||||||||||||
Property / cites work: Two‐stage phase II survival trial design / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / depends on software | |||||||||||||||
Property / depends on software: R / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / depends on software: R / qualifier | |||||||||||||||
software version identifier: ≥ 3.5.0 | |||||||||||||||
Property / MaRDI profile type | |||||||||||||||
Property / MaRDI profile type: MaRDI software profile / rank | |||||||||||||||
Normal rank | |||||||||||||||
links / mardi / name | links / mardi / name | ||||||||||||||
Latest revision as of 19:56, 12 March 2024
Phase II Single-Arm Two-Stage Designs with Time-to-Event Outcomes
Language | Label | Description | Also known as |
---|---|---|---|
English | OneArm2stage |
Phase II Single-Arm Two-Stage Designs with Time-to-Event Outcomes |
Statements
9 October 2023
0 references
Two-stage design for single-arm phase II trials with time-to-event endpoints (e.g., clinical trials on immunotherapies among cancer patients) can be calculated using this package. Two notable advantages of the package: 1) It provides flexible choices from three design methods (optimal, minmax, and admissible), and 2) the power ofthe design is more accurately calculated using the exact variance in theone-sample log-rank test. The package can be used for 1) planning the samplesizes and other design parameters, and 2) conducting the interim and finalanalyses for the Go/No-go decisions. More details about the design methodcan be found in: Wu, J, Chen L, Wei J, Weiss H, Chauhan A. (2020).<doi:10.1002/pst.1983>.
0 references